Generative Biologics

Exciting new features are now available with Generative Biologics! Generative Biologics utilizes advanced algorithms and #machinelearning techniques to expedite the #peptidedesign process. However, we understand that the field of peptide design is multifaceted, and we constantly improve our platform. In the latest version we've added advanced model for in-place 3D-based design of peptides and introduced novel AI-based affinity prediction algorithm for an accurate peptide ranking. To generate peptides on our platform you just need to upload the protein structure. All the steps will be handled by the platform automatically. Besides the developed peptide design workflow, recently we introduced our solutions for epitope-specific Antibody and Nanobody generation. That means that now you are able to overcome one of the main limitations of the conventional design methods – receive biologics which bind exactly where you need. As part of our research and development efforts, we are keen to gain insights directly from experts in the field. For more information, head to our new website today and contact our team https://bit.ly/3YukYvS

?? ????-?????????????? ???????? ?????????????????? ???? ????????????! At #DDIP2025, Petrina Kamya, from Insilico Medicine delivered an insightful presentation on "????????-?????????? ?????????????? ???? ????-???????????? ???????? ?????????????????? ?????? ??????????????????????." ?? She highlighted how AI is accelerating drug discovery by optimizing target identification, reducing development timelines, and enhancing real-world applications in precision medicine. Stay tuned for more updates. #AIinPharma #DrugDiscovery #DDIP2025 #HealthcareInnovation #InsilicoMedicine #Highlights

???? From data exploration to final lead selection, our Generative Biologics platform streamlines #biologicsoptimization using AI-driven insights & robotics-powered validation. Here is the expected timeline: ?? Data Exploration & Model Training (4-5 weeks) ?? Lead Optimization (3-4 weeks/cycle) ? Final Lead Selection (3-5 weeks) With AI-powered analysis, 3D structure modeling, and wet-lab evaluation of the selected binders, we accelerate the journey from variant generation to final candidate validation—helping researchers discover & optimize biologics faster than ever. ?? Learn more about the future of AI in biologics: https://lnkd.in/eeXxqm-G #GenerativeBiologics #AIinBiotech #BiologicsOptimization #AIforDrugDiscovery #PharmaAI

?? Stay Ahead with AI-Powered Drug Discovery! ???? At Insilico Medicine, we’re transforming drug discovery with Pharma.AI. Be sure to follow our Pharma.AI platforms to stay updated on the latest breakthroughs, partnerships, conference presentations, and innovations in AI-driven biologics, small molecule drug design, target discovery, and more. Be sure to follow below ?? ?? Chemistry42 – AI-powered generative chemistry for drug design ?? Generative Biologics – Advancing biologics discovery with AI ?? PandaOmics – AI-driven target discovery and disease insights ?? inClinico – Predicting clinical trial success with AI Follow our platforms to stay informed, connect with experts, and shape the future of AI in pharma! #AIinDrugDiscovery #PharmaAI #GenerativeAI #TargetDiscovery #ClinicalAI #InsilicoMedicine #FollowUs

??? Advancing CNS Therapeutics with Generative AI ???? Insilico And Tenacia Collaborate To Advance CNS Therapeutics With Generative AI The Pharma.AI platform has been instrumental in advancing Insilico’s pipeline of CNS therapeutics, including assets targeting neurodegenerative diseases and other neurological conditions. For instance, the company’s work on ISM001-055, a treatment for idiopathic pulmonary fibrosis, has demonstrated promising results in Phase IIa trials, highlighting the platform’s ability to generate effective drug candidates. Insilico’s focus on CNS therapeutics is driven by the need to address unmet medical needs in neurological disorders. By combining AI-driven innovation with expertise in drug development, Insilico aims to deliver novel treatments that improve outcomes for patients with conditions such as Alzheimer’s disease and epilepsy. Read the latest from Quantum Zeitgeist: https://lnkd.in/eX3qWv8T

?? In case you missed it! Have you seen the new Model Training feature from Generative Biologics? Check out this video here. ??? ?? Users can upload their own experimental data—like affinity values—and train the AI models specifically for their projects. This means you can optimize and screen antibodies and nanobodies more effectively than ever before! Here’s how it works: 1. Upload your experimental data in CSV format. 2. Select the target property (e.g., affinity) for training. 3. Run the model training with just a few clicks! 4. Evaluate the trained model's performance using correlation values and error metrics. If you’re satisfied with the results, deploy the model and use it for future experiments! This feature allows researchers to tailor AI predictions to their specific needs, enhancing biologics development like never before. Check out our screencast to see the feature in action! ?? Get in touch with our team to learn more and book a demo: https://lnkd.in/ewHmSgce

Welcome our first big collaboration in antibody discovery and development with a company which has deep expertise in biologics. Proud to partner with Harbour Biomed - congratulations, teams! And my friend interested in a sophisticated platforms for generative design of biologics check out Generative Biologics and join the community! https://lnkd.in/g4QrJ25z

?? Accelerating Biologics Discovery with AI & Robotics At?Insilico Medicine, we’re revolutionizing biologics discovery by combining the power of our?Generative Biologics Platform?with a fully automated?#roboticslab. Through the integration of cutting-edge?AI-driven insights?and?high-throughput robotic capabilities, we rapidly design, optimize, and test new biologics. By using?experimental data?to continuously refine and fine-tune our models, we ensure our predictions become increasingly accurate, driving faster and more efficient discoveries. This unique synergy of?#AI,?#robotics, and?experimental feedback?is helping us push the boundaries of innovation, accelerating the development of next-generation biologic therapies. Get started with Generative Biologics today: https://lnkd.in/dEmWp5fF

??Train your custom models with Generative Biologics! Experience the power of Custom Model Training and take full control of your predictions like never before! To train your model you need just 4 simple steps: -Upload your list of molecules with experimentally measured properties -Select from a range of advanced algorithms, including LLM-based models, and classical ML techniques -Launch the training process and fine-tune the model with your data -Receive a detailed report comparing model performance and choose the one that best suits your specific needs Our platform's unique ability to retrain #AImodels with your own data allows you to fine-tune predictions and optimize performance for your individual projects. This feature sets us apart, ensuring that your models are more accurate, tailored, and responsive to the nuances of your data. No more one-size-fits-all solutions. With this powerful capability, you can enhance the precision of your predictions and improve outcomes—faster and more effectively than ever before. Ready to try this feature? Reach out today to schedule a demo and see how we can elevate your projects! https://bit.ly/3QbgIfa

??Generative Biologics is an advanced, AI-powered platform that is capable of designing and optimizing different types of biologics including peptides, nanobodies, and antibodies tailored for specific targets. Get an inside look at the capabilities, featuring #Modeltraining, #Predictionworkflow, and so much more. Reach out to our team to learn more: https://bit.ly/40IkiCr #GenerativeBiologics #WorkflowUpdates #GenerativeAI